Anyone taking medications, managing diagnosed health conditions, pregnant or nursing, or with health concerns is appropriately evaluated by healthcare providers when considering GLP-1 medication use
Levels in the low-normal range, between 200 and 300, may warrant supplementation even without overt symptoms, particularly in patients with risk factors for deficiency
If you have any of these, discuss them with your prescriber before starting treatment: Gastroparesis
Results are from a 40-week, randomized, active-controlled trial in 961 adult patients with type 2 diabetes on metformin with or without a sulfonylurea, comparing Ozempic injection 1 mg with Ozempic injection 2 mg
Most providers recommend starting semaglutide about one week after your last tirzepatide injection, aligning with your normal weekly injection schedule